Board Meetings for AUROPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AUROPHARMA | Aurobindo Pharma Limited | 07 Aug 2019 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | |
| AUROPHARMA | Aurobindo Pharma Limited | 28 May 2019 | Financial Results | To consider and approve the financial results for the period ended March 31, 2019 | |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Feb 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and dividend | |
| AUROPHARMA | Aurobindo Pharma Limited | 12 Nov 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and Interim Dividend | |
| AUROPHARMA | Aurobindo Pharma Limited | 09 Aug 2018 | Financial Results | We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Thursday, 9th August, 2018 to consider and approve, inter alia, the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2018.Further to our letter dated 26th July, 2018 informing the closure of Trading Window of the Company from 30th July, 2018 until 48 hours from the date of declaration of the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2018, we would like to inform you that the Trading Window will be closed up to 11th August, 2018 and shall be re-opened on 12th August, 2018. | |
| AUROPHARMA | Aurobindo Pharma Limited | 28 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Feb 2018 | Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 07, 2018 to consider and approve, inter alia, the Un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2017. The company has now inform the exchange that at the aforesaid Board meeting , the Board will also consider the proposal of payment of Second Interim Dividend for the financial Year 2017-18. | |
| AUROPHARMA | Aurobindo Pharma Limited | 07 Feb 2018 | Results | to consider and approve, inter alia, the Un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2017. | |
| AUROPHARMA | Aurobindo Pharma Limited | 09 Nov 2017 | Results/Dividend | to consider and approve, inter alia, the Un-audited Financial results of the Company for the second quarter and half year ended September 30, 2017 and also to consider interim dividend, if any, for the financial year 2017-18. | |
| AUROPHARMA | Aurobindo Pharma Limited | 09 Aug 2017 | Results | To consider and approve, inter alia, the Un-audited Financial Results of the Company for the first quarter ended June 30, 2017. | |
| AUROPHARMA | Aurobindo Pharma Limited | 29 May 2017 | Results/Dividend | to consider and approve, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2017 and also to consider dividend, if any, for the financial year 2016-17. | |
| AUROPHARMA | Aurobindo Pharma Limited | 09 Feb 2017 | Results | to consider, inter alia, the Un-Audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2016. | |
| AUROPHARMA | Aurobindo Pharma Limited | 14 Nov 2016 | Results/Dividend | to consider the Un-audited Financial Results of the Company for the second quarter and half year ended 30th September, 2016 of the FY 2016-17. The Board will also consider the proposal of payment of Interim Dividend for the year 2016-17. | |
| AUROPHARMA | Aurobindo Pharma Limited | 23 Aug 2016 | Results | To consider, inter alia, the Unaudited Financial Results of the Company for the first quarter ended June 30, 2016 of the Financial Year 2016-17. | |
| AUROPHARMA | Aurobindo Pharma Limited | 30 May 2016 | Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended 31st March 2016. Further, the Board will also consider the proposal of payment of Dividend, if any, for the year 2015-16. |